ONTEX Ontex Group N.V.

Ontex reaches binding agreement to sell its Turkish subsidiary to Dilek Grup

Ontex reaches binding agreement to sell its Turkish subsidiary to Dilek Grup

Aalst, Belgium, February 5, 2025 – Ontex Group NV [EURONEXT: ONTEX], a leading international developer and producer of personal care solutions, announces that it has entered into a binding agreement to sell its Turkish subsidiary to Dilek Grup. The transaction includes Ontex’s business in Türkiye and related export business, as well as its plant in Istanbul.

Ontex’s Turkish subsidiary develops, manufactures, commercializes and distributes predominantly branded personal hygiene products with leading positions in Türkiye and the surrounding regions. Ontex’s Turkish subsidiary generated about €90 million sales in 2024 and is part of Ontex’s Emerging Markets division, which has been classified as discontinued operations.

Dilek Grup is an established distributor of fast-moving consumer goods across Türkiye and neighboring countries, and it is diversifying into production of, among others, personal care products.

Laurent Nielly, President Europe, comments: “Ontex is very proud of its business in Türkiye and grateful for the team’s resilience and excellence in execution over the past years, thereby building on, and strengthening, a legacy of strong positions and brands. We believe that Dilek Grup is well placed to further invest in and develop the business and the organization towards the next successful chapter in their journey.

With this agreement, Ontex is approaching the conclusion of its strategic refocus on retail and healthcare brands in Europe and North America. Ontex aims to complete the transaction in the course of the third quarter of 2025, subject to approval by the Turkish competition authority.

Enquiries

  • Investors       Geoffroy Raskin          
  • Media             Catherine Weyne        

About Ontex

Ontex is a leading international developer and producer of baby care, feminine care and adult care products, both for retailers and healthcare. Ontex’s innovative products are distributed in around 100 countries through retailers and healthcare providers. Employing some 7,500 people, Ontex has a presence in 14 countries, with its headquarters in Aalst, Belgium. is listed on and is a constituent of the index. To keep up with the latest news, visit or follow Ontex on .

Attachment



EN
05/02/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ontex Group N.V.

Carole Braudeau
  • Carole Braudeau
CS AXA
CEC CECONOMY AG ... (+13)

Credit Morning 08/01/2025

S&P lowers outlook to negative vs. stable on ELO's 'BB-' rating|ZF H1 25 results: Better than one could have feared… but some water into the wine|Emeria announces the sale of Assurimo|Viridien: Profitability improvement, good FCF generation, and guidance confirmed|

Carole Braudeau
  • Carole Braudeau
CS AXA
CEC CECONOMY AG ... (+13)

Morning Crédit 01/08/2025

ELO : S&P abaisse la perspective de stable à négative sur le rating BB-|ZF H1 25 results: Better than one could have feared… but some water into the wine|Emeria annonce la cession d’Assurimo|Viridien: Profitability improvement, good FCF generation, and guidance confirmed|

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

AB InBev: 2Q25 results. Air France-KLM: Nice beat, let's see how FY25 finishes. AMG: Uptrend continues in 2Q25 with 23% EBITDA beat and guidance up to +US$200m. Aperam: Slight 2Q25 EBITDA beat, 3Q25 seen down QoQ. Arcadis: EBITA margin held up well in 2Q25, order intake mixed. Ayvens: 2Q25 results. Azelis: Soft but largely in-line 2Q25 with EMEA offsetting weaker APAC. Bekaert: 1H25 miss and lowered outlook to result in c.5% consensus downside. Corbion: Taking it to the wire. dsm...

Hilde Van Boxstael ... (+7)
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Michiel Declercq
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi

Morning Notes : ABI BB, ARGX BB, BEKB BB, CRBN NA, DSFIR NA, ENX FP, F...

: ABI BB, ARGX BB, BEKB BB, CRBN NA, DSFIR NA, ENX FP, FAGR BB, FLOW NA, INGA NA, ONTEX BB, UCB BB, AZE BB, SYENS BB

 PRESS RELEASE

Ontex confirms H1 results with revenue and margin decrease in a weaker...

Ontex confirms H1 results with revenue and margin decrease in a weaker-than-expected market, while investing significantly and reaching key transformation milestones Regulated information Revenue drop by 4% in H1, caused mainly by weak baby care demand in Europe;Adj. EBITDA margin down by 2.2pp in H1, due to lower fixed cost absorption caused by lower volumes, and a rising cost environment;Expecting low single digit revenue contraction for full year 2025 and adj. EBITDA in €200-210 million range. CEO quote Gustavo Calvo Paz, Ontex’s CEO, said: “The weak first half of the year, while disa...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch